Although defined in CD4+ T cells, BGRD genes were not enriched in T cell pathways, but were enriched in the Pathways In Cancer (KEGG entry ID hsa05200) (Fig. 1f), a set of 330 cancer genes manually curated from literature20. This evidence concerns the gene CD4 and cancer.